Kintara Therapeutics, Inc. (DMPI) [Rocket]

In millions, except per share items	Mar-31-23	Dec-31-22	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross margin
Selling, general and administrative [+]	3.3	3.5	4.6	5.5	5.4	5.9	6.0	6.7
General and administrative				5.5				6.7
Other selling, general and administrative
Research and development
Other operating expenses	-0.1	-0.1	-0.1	-1.6	0.0	0.0	0.0	1.3
Depreciation and amortization
EBIT [+]	-3.2	-3.4	-4.5	-3.9	-5.4	-5.9	-6.0	-8.0
EBIT growth	-39.7%	-42.1%	-23.7%	-51.7%	-19.7%	8.1%	324.9%	411.7%
EBIT margin
Non-recurring items				1.6				-1.6
Interest expense								0.0
Interest expense								0.0
Other income (expense), net	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.2
Pre-tax income	-3.3	-3.5	-4.6	-5.4	-5.4	-5.9	-6.0	-6.7
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-3.3	-3.5	-4.6	-5.4	-5.4	-5.9	-6.0	-6.7
Net margin

Basic EPS [+]	($1.94)	($2.10)	($0.06)	($0.11)	($5.45)	($6.07)	($0.17)	($0.26)
Growth	-64.4%	-65.4%	-63.9%	-57.0%	2303.9%	2682.5%	-86.9%	-81.2%
Diluted EPS [+]	($1.94)	($2.10)	($0.06)	($0.11)	($5.45)	($6.07)	($0.17)	($0.26)
Growth	-64.4%	-65.4%	-63.9%	-57.0%	2303.9%	2682.5%	-86.9%	-81.2%

Shares outstanding (basic) [+]	1.7	1.6	73.2	48.7	1.0	1.0	34.3	25.9
Growth	71.0%	69.2%	113.5%	88.1%	-96.6%	-96.1%	100.4%	147.9%
Shares outstanding (diluted) [+]	1.7	1.6	73.2	48.7	1.0	1.0	34.3	25.9
Growth	71.0%	69.2%	113.5%	88.1%	-96.6%	-96.1%	100.4%	147.9%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.